Greenland Mines Ltd. Common Stock (GRML) Competitors $0.39 0.00 (0.00%) As of 05/22/2026 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRML vs. DTIL, SLGL, IFRX, CRBP, and KPTIShould you buy Greenland Mines Ltd. Common Stock stock or one of its competitors? MarketBeat compares Greenland Mines Ltd. Common Stock with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Greenland Mines Ltd. Common Stock include Precision BioSciences (DTIL), Sol-Gel Technologies (SLGL), InflaRx (IFRX), Corbus Pharmaceuticals (CRBP), and Karyopharm Therapeutics (KPTI). These companies are all part of the "pharmaceutical products" industry. GRML vs. DTILGRML vs. SLGLGRML vs. IFRXGRML vs. CRBPGRML vs. KPTIHow does Greenland Mines Ltd. Common Stock compare to Precision BioSciences?Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Precision BioSciences (NASDAQ:DTIL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability. Does the media refer more to GRML or DTIL? In the previous week, Greenland Mines Ltd. Common Stock and Greenland Mines Ltd. Common Stock both had 3 articles in the media. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.46 beat Precision BioSciences' score of -0.05 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Precision BioSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, GRML or DTIL? Greenland Mines Ltd. Common Stock has a beta of 7.61, meaning that its stock price is 661% more volatile than the broader market. Comparatively, Precision BioSciences has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market. Which has preferable earnings and valuation, GRML or DTIL? Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than Precision BioSciences. Precision BioSciences is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGreenland Mines Ltd. Common StockN/AN/A-$10.55M-$0.25N/APrecision BioSciences$34.26M5.44-$45.72M-$3.67N/A Is GRML or DTIL more profitable? Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to Precision BioSciences' net margin of -96.73%. Precision BioSciences' return on equity of -85.37% beat Greenland Mines Ltd. Common Stock's return on equity.Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common StockN/A -109.40% -98.80% Precision BioSciences -96.73%-85.37%-37.34% Do analysts recommend GRML or DTIL? Precision BioSciences has a consensus target price of $24.50, suggesting a potential upside of 238.87%. Given Precision BioSciences' stronger consensus rating and higher probable upside, analysts clearly believe Precision BioSciences is more favorable than Greenland Mines Ltd. Common Stock.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Precision BioSciences 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do insiders & institutionals hold more shares of GRML or DTIL? 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 38.0% of Precision BioSciences shares are held by institutional investors. 9.9% of Greenland Mines Ltd. Common Stock shares are held by insiders. Comparatively, 2.7% of Precision BioSciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryGreenland Mines Ltd. Common Stock and Precision BioSciences tied by winning 7 of the 14 factors compared between the two stocks.How does Greenland Mines Ltd. Common Stock compare to Sol-Gel Technologies?Sol-Gel Technologies (NASDAQ:SLGL) and Greenland Mines Ltd. Common Stock (NASDAQ:GRML) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends. Which has preferable earnings & valuation, SLGL or GRML? Sol-Gel Technologies has higher revenue and earnings than Greenland Mines Ltd. Common Stock. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSol-Gel Technologies$19.39M11.12-$6.13M-$2.23N/AGreenland Mines Ltd. Common StockN/AN/A-$10.55M-$0.25N/A Does the media favor SLGL or GRML? In the previous week, Sol-Gel Technologies had 9 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 12 mentions for Sol-Gel Technologies and 3 mentions for Greenland Mines Ltd. Common Stock. Sol-Gel Technologies' average media sentiment score of 1.01 beat Greenland Mines Ltd. Common Stock's score of 0.46 indicating that Sol-Gel Technologies is being referred to more favorably in the media. Company Overall Sentiment Sol-Gel Technologies Positive Greenland Mines Ltd. Common Stock Neutral Which has more risk & volatility, SLGL or GRML? Sol-Gel Technologies has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market. Comparatively, Greenland Mines Ltd. Common Stock has a beta of 7.61, indicating that its stock price is 661% more volatile than the broader market. Is SLGL or GRML more profitable? Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -31.60%. Sol-Gel Technologies' return on equity of -24.29% beat Greenland Mines Ltd. Common Stock's return on equity.Company Net Margins Return on Equity Return on Assets Sol-Gel Technologies-31.60% -24.29% -18.73% Greenland Mines Ltd. Common Stock N/A -109.40%-98.80% Do insiders & institutionals believe in SLGL or GRML? 26.2% of Sol-Gel Technologies shares are held by institutional investors. Comparatively, 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. 66.5% of Sol-Gel Technologies shares are held by company insiders. Comparatively, 9.9% of Greenland Mines Ltd. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer SLGL or GRML? Sol-Gel Technologies presently has a consensus target price of $110.00, indicating a potential upside of 43.36%. Given Sol-Gel Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe Sol-Gel Technologies is more favorable than Greenland Mines Ltd. Common Stock.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sol-Gel Technologies 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.75Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummarySol-Gel Technologies beats Greenland Mines Ltd. Common Stock on 12 of the 16 factors compared between the two stocks.How does Greenland Mines Ltd. Common Stock compare to InflaRx?Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and InflaRx (NASDAQ:IFRX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Do analysts prefer GRML or IFRX? InflaRx has a consensus price target of $7.00, indicating a potential upside of 168.20%. Given InflaRx's stronger consensus rating and higher possible upside, analysts clearly believe InflaRx is more favorable than Greenland Mines Ltd. Common Stock.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00InflaRx 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.71 Is GRML or IFRX more profitable? InflaRx's return on equity of -88.30% beat Greenland Mines Ltd. Common Stock's return on equity.Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common StockN/A -109.40% -98.80% InflaRx N/A -88.30%-65.77% Which has higher earnings and valuation, GRML or IFRX? Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than InflaRx. InflaRx is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGreenland Mines Ltd. Common StockN/AN/A-$10.55M-$0.25N/AInflaRx$30K6,289.23-$51.63M-$0.71N/A Does the media refer more to GRML or IFRX? In the previous week, Greenland Mines Ltd. Common Stock had 2 more articles in the media than InflaRx. MarketBeat recorded 3 mentions for Greenland Mines Ltd. Common Stock and 1 mentions for InflaRx. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.46 beat InflaRx's score of 0.00 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InflaRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, GRML or IFRX? Greenland Mines Ltd. Common Stock has a beta of 7.61, meaning that its stock price is 661% more volatile than the broader market. Comparatively, InflaRx has a beta of 2.42, meaning that its stock price is 142% more volatile than the broader market. Do institutionals & insiders believe in GRML or IFRX? 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 42.4% of InflaRx shares are held by institutional investors. 9.9% of Greenland Mines Ltd. Common Stock shares are held by company insiders. Comparatively, 16.3% of InflaRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryInflaRx beats Greenland Mines Ltd. Common Stock on 9 of the 15 factors compared between the two stocks.How does Greenland Mines Ltd. Common Stock compare to Corbus Pharmaceuticals?Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Corbus Pharmaceuticals (NASDAQ:CRBP) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends. Which has stronger earnings and valuation, GRML or CRBP? Corbus Pharmaceuticals is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGreenland Mines Ltd. Common StockN/AN/A-$10.55M-$0.25N/ACorbus PharmaceuticalsN/AN/A-$78.54M-$5.82N/A Is GRML or CRBP more profitable? Corbus Pharmaceuticals' return on equity of -70.89% beat Greenland Mines Ltd. Common Stock's return on equity.Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common StockN/A -109.40% -98.80% Corbus Pharmaceuticals N/A -70.89%-61.78% Do institutionals and insiders hold more shares of GRML or CRBP? 20.1% of Greenland Mines Ltd. Common Stock shares are owned by institutional investors. Comparatively, 64.6% of Corbus Pharmaceuticals shares are owned by institutional investors. 9.9% of Greenland Mines Ltd. Common Stock shares are owned by company insiders. Comparatively, 3.5% of Corbus Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, GRML or CRBP? Greenland Mines Ltd. Common Stock has a beta of 7.61, meaning that its share price is 661% more volatile than the broader market. Comparatively, Corbus Pharmaceuticals has a beta of 2.68, meaning that its share price is 168% more volatile than the broader market. Does the media refer more to GRML or CRBP? In the previous week, Corbus Pharmaceuticals had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 4 mentions for Corbus Pharmaceuticals and 3 mentions for Greenland Mines Ltd. Common Stock. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.46 beat Corbus Pharmaceuticals' score of 0.27 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Corbus Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Do analysts prefer GRML or CRBP? Corbus Pharmaceuticals has a consensus price target of $42.89, suggesting a potential upside of 277.88%. Given Corbus Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Corbus Pharmaceuticals is more favorable than Greenland Mines Ltd. Common Stock.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Corbus Pharmaceuticals 2 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.75 SummaryCorbus Pharmaceuticals beats Greenland Mines Ltd. Common Stock on 8 of the 14 factors compared between the two stocks.How does Greenland Mines Ltd. Common Stock compare to Karyopharm Therapeutics?Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Karyopharm Therapeutics (NASDAQ:KPTI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation. Do institutionals & insiders hold more shares of GRML or KPTI? 20.1% of Greenland Mines Ltd. Common Stock shares are owned by institutional investors. Comparatively, 66.4% of Karyopharm Therapeutics shares are owned by institutional investors. 9.9% of Greenland Mines Ltd. Common Stock shares are owned by insiders. Comparatively, 1.7% of Karyopharm Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts prefer GRML or KPTI? Karyopharm Therapeutics has a consensus target price of $17.17, suggesting a potential upside of 110.38%. Given Karyopharm Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Karyopharm Therapeutics is more favorable than Greenland Mines Ltd. Common Stock.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Karyopharm Therapeutics 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86 Does the media refer more to GRML or KPTI? In the previous week, Greenland Mines Ltd. Common Stock had 2 more articles in the media than Karyopharm Therapeutics. MarketBeat recorded 3 mentions for Greenland Mines Ltd. Common Stock and 1 mentions for Karyopharm Therapeutics. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.46 beat Karyopharm Therapeutics' score of 0.00 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Karyopharm Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, GRML or KPTI? Greenland Mines Ltd. Common Stock has a beta of 7.61, meaning that its share price is 661% more volatile than the broader market. Comparatively, Karyopharm Therapeutics has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market. Which has better valuation and earnings, GRML or KPTI? Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than Karyopharm Therapeutics. Greenland Mines Ltd. Common Stock is trading at a lower price-to-earnings ratio than Karyopharm Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGreenland Mines Ltd. Common StockN/AN/A-$10.55M-$0.25N/AKaryopharm Therapeutics$146.07M1.27-$196.04M-$15.09N/A Is GRML or KPTI more profitable? Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to Karyopharm Therapeutics' net margin of -129.02%. Karyopharm Therapeutics' return on equity of 0.00% beat Greenland Mines Ltd. Common Stock's return on equity.Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common StockN/A -109.40% -98.80% Karyopharm Therapeutics -129.02%N/A -120.29% SummaryGreenland Mines Ltd. Common Stock and Karyopharm Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get Greenland Mines Ltd. Common Stock News Delivered to You Automatically Sign up to receive the latest news and ratings for GRML and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRML and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRML vs. The Competition ExportMetricGreenland Mines Ltd. Common StockMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$47.27M$3.04B$6.45B$12.34BDividend YieldN/A1.97%2.76%5.28%P/E Ratio-1.5612.5217.9322.89Price / SalesN/A336.21553.9286.28Price / CashN/A57.7443.4956.67Price / Book0.935.8610.377.14Net Income-$10.55M$74.99M$3.57B$335.98M7 Day Performance10.42%2.55%6.01%3.56%1 Month Performance-19.56%-3.05%3.52%2.54%1 Year Performance102.76%34.38%34.13%35.05% Greenland Mines Ltd. Common Stock Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRMLGreenland Mines Ltd. Common Stock1.0338 of 5 stars$0.39flatN/A+102.8%$47.27MN/AN/A5Earnings ReportGap UpDTILPrecision BioSciences1.9161 of 5 stars$7.17+3.9%$36.33+407.0%+57.9%$184.26M$34.26MN/A200SLGLSol-Gel Technologies3.6121 of 5 stars$65.15+2.9%$110.00+68.8%+910.9%$181.24M$19.39MN/A50Positive NewsGap DownIFRXInflaRx2.6011 of 5 stars$2.49+5.1%$7.00+181.1%+41.1%$179.64M$30KN/A60Gap UpCRBPCorbus Pharmaceuticals2.5583 of 5 stars$9.67+5.6%$42.33+338.0%+53.4%$179.44MN/AN/A40Analyst Forecast Related Companies and Tools Related Companies Precision BioSciences Competitors Sol-Gel Technologies Competitors InflaRx Competitors Corbus Pharmaceuticals Competitors Karyopharm Therapeutics Competitors Oramed Pharmaceuticals Competitors Tenaya Therapeutics Competitors Acumen Pharmaceuticals Competitors Lifecore Biomedical Competitors Journey Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRML) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenland Mines Ltd. Common Stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenland Mines Ltd. Common Stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
